Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)

Trial Phase 2 Active, not recruiting Oct. 26, 2022

Deep Brain Stimulation (DBS) for Parkinson's Disease International Study

Trial N/A Completed Oct. 19, 2022

Establishing Alpha-synuclein RT-QuIC Assay as a Diagnostic Technique in REM Sleep Behaviour Disorder

Trial N/A Withdrawn Oct. 17, 2022

The Effect and Mechanism of Transcutaneous Auricular Vagus Nerve Stimulation on Gait Impairments in PD

Trial N/A Unknown Oct. 17, 2022

DESENSITIZE-PD: Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Support Dopaminergic Desensitization in PD

Trial N/A Unknown Oct. 17, 2022

Parkinson's Disease With Mild Cognitive Impairment Treated With Nicotinic Agonist Drug

Trial Phase 2 Withdrawn Oct. 13, 2022

Measuring Parkinson's Disease Progression

Trial Phase 1 Completed Oct. 13, 2022

PA Behavior and HRQoL in Parkinson's Disease Patients Patients: Role of Social Cognitive Variables

Trial N/A Completed Oct. 11, 2022

Parkinson's Research With Inclusion, Diversity and Equity

Trial N/A Unknown Oct. 9, 2022

Study Assessing Efficacy and Safety of AKST4290 in Subjects With Parkinson's Disease on Stable Dopaminergic Treatment

Trial Phase 2 Completed Oct. 9, 2022

Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD)

Trial Phase 2 Completed Oct. 5, 2022

The WalkingTall Study: Comparing WalkingTall With Parkinson's Disease (WalkingTall-PD) With Mobility-plus to Reduce Falls and Improve Mobility.

Trial N/A Completed Oct. 4, 2022

The Efficacy of a Remote Cognitive Remediation Therapy (CRT) Program on Parkinson's Disease

Trial N/A Completed Oct. 4, 2022

Effects of a Biomechanical-based Tai Chi Program on Gait and Posture in People With Parkinson's Disease

Trial N/A Completed Oct. 3, 2022

Brain Stimulation for Patients With Parkinson Disease

Trial N/A Completed Oct. 2, 2022

Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease

Trial N/A Unknown Sept. 27, 2022

Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm

Trial Phase 1 Completed Sept. 26, 2022

The Effects of Vibrotactile Stimulation in Patients With Movement Disorders

Trial N/A Completed Sept. 26, 2022

Lundbeck TOMs Orthostatic Hypotension

Trial Phase 4 Completed Sept. 25, 2022

A Study of E2027 in Participants With Dementia With Lewy Bodies (DLB) or Parkinson's Disease Dementia (PDD) With or Without Amyloid Copathology

Trial Phase 2 Completed Sept. 25, 2022